A Step-by-Step Approach to Improve Clinical Translation of Liposome-Based Nanomaterials, a Focus on Innate Immune and Inflammatory Responses

This study aims to provide guidelines to design and perform a robust and reliable physical-chemical characterization of liposome-based nanomaterials, and to support method development with a specific focus on their inflammation-inducing potential. Out of eight differently functionalized liposomes se...

Full description

Bibliographic Details
Main Authors: Giacomo Della Camera, Dorelia Lipsa, Dora Mehn, Paola Italiani, Diana Boraschi, Sabrina Gioria
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/2/820
_version_ 1797411155572948992
author Giacomo Della Camera
Dorelia Lipsa
Dora Mehn
Paola Italiani
Diana Boraschi
Sabrina Gioria
author_facet Giacomo Della Camera
Dorelia Lipsa
Dora Mehn
Paola Italiani
Diana Boraschi
Sabrina Gioria
author_sort Giacomo Della Camera
collection DOAJ
description This study aims to provide guidelines to design and perform a robust and reliable physical-chemical characterization of liposome-based nanomaterials, and to support method development with a specific focus on their inflammation-inducing potential. Out of eight differently functionalized liposomes selected as “case-studies”, three passed the physical-chemical characterization (in terms of size-distribution, homogeneity and stability) and the screening for bacterial contamination (sterility and apyrogenicity). Although all three were non-cytotoxic when tested in vitro, they showed a different capacity to activate human blood cells. HSPC/CHOL-coated liposomes elicited the production of several inflammation-related cytokines, while DPPC/CHOL- or DSPC/CHOL-functionalized liposomes did not. This work underlines the need for accurate characterization at multiple levels and the use of reliable in vitro methods, in order to obtain a realistic assessment of liposome-induced human inflammatory response, as a fundamental requirement of nanosafety regulations.
first_indexed 2024-03-09T04:40:59Z
format Article
id doaj.art-665d502e4eed4f6e96b623eaa7e02397
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T04:40:59Z
publishDate 2021-01-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-665d502e4eed4f6e96b623eaa7e023972023-12-03T13:21:02ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-01-0122282010.3390/ijms22020820A Step-by-Step Approach to Improve Clinical Translation of Liposome-Based Nanomaterials, a Focus on Innate Immune and Inflammatory ResponsesGiacomo Della Camera0Dorelia Lipsa1Dora Mehn2Paola Italiani3Diana Boraschi4Sabrina Gioria5European Commission, Joint Research Centre (JRC), 21027 Ispra, ItalyEuropean Commission, Joint Research Centre (JRC), 21027 Ispra, ItalyEuropean Commission, Joint Research Centre (JRC), 21027 Ispra, ItalyInstitute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), 80131 Naples, ItalyInstitute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), 80131 Naples, ItalyEuropean Commission, Joint Research Centre (JRC), 21027 Ispra, ItalyThis study aims to provide guidelines to design and perform a robust and reliable physical-chemical characterization of liposome-based nanomaterials, and to support method development with a specific focus on their inflammation-inducing potential. Out of eight differently functionalized liposomes selected as “case-studies”, three passed the physical-chemical characterization (in terms of size-distribution, homogeneity and stability) and the screening for bacterial contamination (sterility and apyrogenicity). Although all three were non-cytotoxic when tested in vitro, they showed a different capacity to activate human blood cells. HSPC/CHOL-coated liposomes elicited the production of several inflammation-related cytokines, while DPPC/CHOL- or DSPC/CHOL-functionalized liposomes did not. This work underlines the need for accurate characterization at multiple levels and the use of reliable in vitro methods, in order to obtain a realistic assessment of liposome-induced human inflammatory response, as a fundamental requirement of nanosafety regulations.https://www.mdpi.com/1422-0067/22/2/820nanomaterialliposomesafety assessmentnanomedicineparticle size distributionphysicochemical characterization
spellingShingle Giacomo Della Camera
Dorelia Lipsa
Dora Mehn
Paola Italiani
Diana Boraschi
Sabrina Gioria
A Step-by-Step Approach to Improve Clinical Translation of Liposome-Based Nanomaterials, a Focus on Innate Immune and Inflammatory Responses
International Journal of Molecular Sciences
nanomaterial
liposome
safety assessment
nanomedicine
particle size distribution
physicochemical characterization
title A Step-by-Step Approach to Improve Clinical Translation of Liposome-Based Nanomaterials, a Focus on Innate Immune and Inflammatory Responses
title_full A Step-by-Step Approach to Improve Clinical Translation of Liposome-Based Nanomaterials, a Focus on Innate Immune and Inflammatory Responses
title_fullStr A Step-by-Step Approach to Improve Clinical Translation of Liposome-Based Nanomaterials, a Focus on Innate Immune and Inflammatory Responses
title_full_unstemmed A Step-by-Step Approach to Improve Clinical Translation of Liposome-Based Nanomaterials, a Focus on Innate Immune and Inflammatory Responses
title_short A Step-by-Step Approach to Improve Clinical Translation of Liposome-Based Nanomaterials, a Focus on Innate Immune and Inflammatory Responses
title_sort step by step approach to improve clinical translation of liposome based nanomaterials a focus on innate immune and inflammatory responses
topic nanomaterial
liposome
safety assessment
nanomedicine
particle size distribution
physicochemical characterization
url https://www.mdpi.com/1422-0067/22/2/820
work_keys_str_mv AT giacomodellacamera astepbystepapproachtoimproveclinicaltranslationofliposomebasednanomaterialsafocusoninnateimmuneandinflammatoryresponses
AT dorelialipsa astepbystepapproachtoimproveclinicaltranslationofliposomebasednanomaterialsafocusoninnateimmuneandinflammatoryresponses
AT doramehn astepbystepapproachtoimproveclinicaltranslationofliposomebasednanomaterialsafocusoninnateimmuneandinflammatoryresponses
AT paolaitaliani astepbystepapproachtoimproveclinicaltranslationofliposomebasednanomaterialsafocusoninnateimmuneandinflammatoryresponses
AT dianaboraschi astepbystepapproachtoimproveclinicaltranslationofliposomebasednanomaterialsafocusoninnateimmuneandinflammatoryresponses
AT sabrinagioria astepbystepapproachtoimproveclinicaltranslationofliposomebasednanomaterialsafocusoninnateimmuneandinflammatoryresponses
AT giacomodellacamera stepbystepapproachtoimproveclinicaltranslationofliposomebasednanomaterialsafocusoninnateimmuneandinflammatoryresponses
AT dorelialipsa stepbystepapproachtoimproveclinicaltranslationofliposomebasednanomaterialsafocusoninnateimmuneandinflammatoryresponses
AT doramehn stepbystepapproachtoimproveclinicaltranslationofliposomebasednanomaterialsafocusoninnateimmuneandinflammatoryresponses
AT paolaitaliani stepbystepapproachtoimproveclinicaltranslationofliposomebasednanomaterialsafocusoninnateimmuneandinflammatoryresponses
AT dianaboraschi stepbystepapproachtoimproveclinicaltranslationofliposomebasednanomaterialsafocusoninnateimmuneandinflammatoryresponses
AT sabrinagioria stepbystepapproachtoimproveclinicaltranslationofliposomebasednanomaterialsafocusoninnateimmuneandinflammatoryresponses